Scinai Immunotherapeutics Ltd. Posts 167% Revenue Growth Through September
Photo: TokenPost
Scinai Immunotherapeutics Ltd. generated $2.80 million in revenue over the nine months through Sept. 30, 2026, a 167% increase from the same period in 2025. Its net loss for the period was $390,000, down from $6.24 million in the first nine months of 2025. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
